Products and Services
-
Inhalon Biopharma announced that it has contracted with hVIVO to conduct a Phase 2a challenge study of nebulized IN-002, an antibody against RSV, now that Inhalon has completed IND-enabling studies. The company said that it… Read more . . .
-
OINDP specialist contract developer Kenox Pharmaceuticals announced that it has added a clean room for small scale manufacturing of non-sterile nasal sprays and dry powders for use in pre-clinical development. The company, which is located… Read more . . .
-
OINDP testing specialists Copley Scientific have announced the launch of the new Powder Testing Workstation PTW for flowability testing as well as the Powder Testing Assistant PTA 100i. The customizable PTW system allows the user to select various modules… Read more . . .
-
KAER Biotherapeutics has announced the launch of the AeroPulsR aerosol device for delivery of high doses of aqueous aerosols in critical care settings. According to KAER, the AeroPulsR can deliver liquids of viscosities up to… Read more . . .
-
Nemera and Nipro Pharma Packaging have announced the conclusion of compatibility testing of Nemera’s UniSpray nasal pump with Nipro’s unit dose “microvials.” According to the companies, the tests demonstrated complete compatibility and meet requirements for… Read more . . .
-
Lactose supplier DFE Pharma has announced the availability of analytical services for dry powder inhaler formulations at its Closer to the Formulator (C2F) Center of Excellence in Hyderabad, India, in response to growing demand. According to DFE,… Read more . . .
-
Spray drying experts Lonza will develop spray dried dry powder formulations for delivery by Iconovo‘s ICOone Nasal device, the companies announced. According to the announcement, the collaboration involves “a reformulated substance for obesity.” In May 2024,… Read more . . .
-
Phillips Medisize announced that its parent company Molex has completed its acquisition of inhalation CDMO Vectura, which was initially announced in September 2024. According to the announcement, the acquisition covers all of Vectura’s assets in… Read more . . .
-
Merxin Ltd and contract device manufacturer OECHSLERhealth have announced the formation of a strategic partnership called The SMI PowerHouse for manufacturing of Merxin’s MRX004 soft mist inhaler, a generic version of the Respimat device. According… Read more . . .
-
Intertek, which provides a wide range of testing services for OINDPs, has announced a new partnership with particle engineering specialist CrystecPharma for creation of a “fast to clinic” development platform for dry powder inhaler formulations.… Read more . . .
Featured event:
Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
October 14-October 15: Advancing Bioequivalence Frameworks for Inhalation and Nasal Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods, Rockville, MD, USA
October 19-October 20: MVIC Autumn Training 2026, Lund, Sweden
October 21-October 22: MVIC Symposium, Lund, Sweden
October 28-October 30: Deutches Aerosol Therapie Symposium (DATS), Marburg, Germany
November 10-November 11: Rescon Europe 2026, Porto, Portugal